Mynvax is a clinical-stage vaccine biotechnology company based in Bengaluru, India, developing recombinant, thermostable vaccines for respiratory viral infections. Spun out of the Indian Institute of Science (IISc), the company applies protein-stabilization and structure-based antigen design to create thermotolerant COVID-19 and influenza vaccine… - View it on GitHub